You are here: Industry Insights > hepatitis B

News List

Chinese Produced ASO Drug Innovation Therapy for Functional Cure of Chronic Hepatitis B Has Obtained FDA Clinical Approval Xiaoyaowan/Pharmasources
September 08, 2023
Recently, Haobo Pharmaceuticals announced that their investigational antisense oligonucleotide (ASO) drug AHB-137 has received clinical trial approval from the FDA in the United States for use in patients with chronic hepatitis B.
Brii Bio Doses First Patient in Phase 2a/2b Clinical Trial of BRII-179 (VBI-2601) for the Functional Cure of Chronic Hepatitis B prnasia
December 28, 2021
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens...
Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r) prnasia
June 18, 2021
Gilead Sciences, Inc. today announced new sub-analysis data from a Phase 2 open-label study (GS-US-320-4035; NCT03180619), evaluating the safety and efficacy of switching to Vemlidy®# (tenofovir alafenamide 25 mg, TAF) from ...
Dynavax secures EC marketing authorisation for hepatitis B vaccine pharmaceutical-business-review
February 25, 2021
Biopharmaceutical company Dynavax Technologies (DVAX) has secured marketing authorisation from the European Commission (EC) for Heplisav B, a two-dose adult hepatitis B adjuvanted vaccine.
Gilead and Vir unite to find a ‘functional cure’ for hepatitis B pharmatimes
January 15, 2021
Gilead Sciences and Vir Biotechnology have partnered to evaluate novel therapeutic combination strategies aimed at developing a ‘functional cure’ for chronic hepatitis B virus (HBV).
European CHMP adopts positive opinion for Dynavax’s HEPLISAV-B vaccine for Hepatitis B pharmaceutical-business-review
December 15, 2020
Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ...
Screen Every Pregnant Woman for Hep B: Task Force drugs
July 24, 2019
All pregnant women should be screened early for hepatitis B, to prevent the viral infection from being passed to newborns.
Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases pharmafocusasia
January 17, 2019
Ascletis Pharma Inc and Suzhou Alphamab Co., Ltd. (Alphamab) jointly announce today that Ascletis' subsidiary and Alphamab have entered into a strategic collaboration and exclusive licensing agreement for .....
Gilead taps gene editors at Precision BioSciences for hepatitis B cure development fiercebiotech
September 14, 2018
Precision’s platform is derived from a natural enzyme that can target specific gene locations and insert or delete DNA, disrupting sequences.
NFID Initiative Working to Up Hepatitis B Vaccination Rates drugs
July 30, 2018
A new initiative to increase hepatitis B virus vaccination rates among at-risk adults has been developed, according to a report from the National Foundation for Infectious Diseases (NFID) published in support of World Hepatitis Day.

Previous page 1 2 Next page